Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy

Volume: 21, Issue: 9, Pages: e431 - e443
Published: Sep 1, 2020
Abstract
Peptide receptor radionuclide therapy (PRRT) is a type of radiotherapy that targets peptide receptors and is typically used for neuroendocrine tumours (NETs). Some of the key challenges in its use are the prediction of efficacy and toxicity, patient selection, and response optimisation. In this Review, we assess current knowledge on the molecular profile of NETs and the strategies and tools used to predict, monitor, and assess the toxicity of...
Paper Details
Title
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy
Published Date
Sep 1, 2020
Volume
21
Issue
9
Pages
e431 - e443
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.